Clinical Trial Update: Establishment of ProNephro AKI (NGAL) Cut Off Value for Risk Assessment of Moderate to Severe Acute Kidney Injury in Adults

View source ↗

Summary

A clinical trial is evaluating and establishing a NGAL-based cut-off value (ProNephro AKI) to assess the risk of moderate to severe acute kidney injury in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Snippet

Sponsor: BioPorto Diagnostics | Conditions: Acute Kidney Injury | Status: ACTIVE_NOT_RECRUITING